Glimepiride / Metformin Tablet bulk supplier for pharma manufacturers

Glimepiride / Metformin Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: Glimepiride 1mg/2mg/3mg/4mg + Metformin 500mg/850mg/1000mg

Reference Brands: Amaryl M

Category: Diabetes

Glimepiride stimulates insulin release from pancreatic β-cells, while Metformin decreases hepatic glucose production and improves insulin sensitivity. Together, they provide complementary actions for better glycemic control in type 2 diabetes. This dual therapy helps reduce fasting and postprandial blood glucose levels, often with fewer side effects than high-dose monotherapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Glimepiride + Metformin fixed-dose combination (FDC) tablets are approved in the EU for the management of type 2 diabetes mellitus when monotherapy with either agent is insufficient. EU regulatory bodies support their use based on proven glycemic control efficacy and safety. In the USA, FDCs with Glimepiride are not widely available as branded drugs but may be compounded or prescribed off-label in generic forms. These combinations must meet bioequivalence, labeling, and GMP standards under EMA and FDA guidelines. Pharmatradz.com helps connect buyers with reliable manufacturers offering Glimepiride + Metformin tablets aligned with regional regulatory frameworks.

Glimepiride / Metformin Tablet — third party manufacturing & bulk supply

Glimepiride / Metformin Tablet is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Glimepiride / Metformin Tablet is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Glimepiride / Metformin Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Glimepiride / Metformin Tablet →

Back to Listing

Frequently Asked Questions

Glimepiride / Metformin is used to control blood sugar levels in patients with type 2 diabetes mellitus when diet and exercise alone are not sufficient. It helps improve insulin secretion and reduce glucose production in the body.

This medicine is made from two active ingredients: Glimepiride, a sulfonylurea that stimulates insulin release from the pancreas, and Metformin hydrochloride, a biguanide that decreases glucose production in the liver and improves insulin sensitivity.

Glimepiride / Metformin is marketed under various trade names worldwide, including Amaryl M, Glimepiride Metformin, and other regional brand names depending on the manufacturer.

Glimepiride / Metformin is manufactured by multiple pharmaceutical companies globally, including Sanofi and several generic manufacturers.

The generic name is Glimepiride and Metformin hydrochloride.

Brand names include Amaryl M and other Glimepiride / Metformin combination brands depending on the country and manufacturer.

Glimepiride / Metformin is manufactured in various countries including the USA, EU member states, India, and the UK by different pharmaceutical companies.